Deciphera Pharmaceuticals (DCPH) Price-to-Earnings (P/E) Ratio
Price: $25.59
Market Cap: $2.21B
Avg Volume: 1.86M
Market Cap: $2.21B
Avg Volume: 1.86M
Country: US
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Deciphera Pharmaceuticals's P/E ratios across different time periods:
- TTM: -11.74
- Annual: -7.04
- Quarterly: -7.64
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 3.91
- Price-to-Sales (P/S) Ratio: 8.40
Annual Ratios
Deciphera Pharmaceuticals Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-11.74
P/B Ratio (Annual)
3.91
P/S Ratio (Annual)
8.40
Deciphera Pharmaceuticals Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2023 | -7.04 | 3.91 | 8.40 |
| 2022 | -6.92 | 3.62 | 9.23 |
| 2021 | -1.91 | 1.86 | 5.90 |
| 2020 | -11.95 | 5.86 | 75.64 |
| 2019 | -13.93 | 4.88 | 106.73 |
| 2018 | -7.44 | 2.65 | 0.00 |
| 2017 | -7.57 | 2.07 | 0.00 |
| 2016 | -14.22 | -2.64 | 0.00 |
| 2015 | -18.61 | -3.20 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for DCPH.